NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/16/2026
Back to search
Official data from USPTO
ORYZON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
06/17/2026
Trademark type
Combined
Nice classes
42
Filing date
04/17/2015
Registration date
03/15/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2026
Last transaction
06/17/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Madrid, ES
Examiner
BLOHM, LINDA
Current location
Historical data usage
Mark description
The mark consists of the term "ORYZON", written in white stylized letters on a black rectangular background; in the center of the letter "O" is a blue dot.
Holders and representatives
Holders
ORYZON GENOMICS, S.A.
ORYZON GENOMICS, S.A.
Representatives
Louis J. Levy Symbus Law Group PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Researchdiscovery and development of therapeutic products and diagnostic products and methods in the field of epigenetics; medical and scientific research in the field of oncologicalhematologicalproliferativeneurologicalinflammatorymetabolicautoimmunecardiovasculargastrointestinal and infectious diseases; medical research; biotechnology research; chemical research; pharmaceutical products development; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals for the treatment of oncologicalhematologicalproliferativeneurologicalinflammatorymetabolicautoimmunecardiovasculargastrointestinal and infectious diseases; conducting evaluations in the field of new pharmaceuticals
Publications
History of USPTO decisions and trademark events.
43 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
06/16/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/15/2026
ES71
TEAS SECTION 71 RECEIVED
03/02/2026
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/08/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/15/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/08/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/08/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/08/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/04/2023
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
08/06/2022
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
08/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/02/2022
ES75
TEAS SECTION 71 & 15 RECEIVED
03/04/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/03/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/15/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/22/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/01/2016
FIMP
FINAL DISPOSITION PROCESSED
07/01/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/15/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
03/15/2016
GPNX
NOTIFICATION PROCESSED BY IB
01/04/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/29/2015
PUBO
PUBLISHED FOR OPPOSITION
12/29/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/16/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/16/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/09/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/02/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/21/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/20/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/20/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/19/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/19/2015
RFNT
REFUSAL PROCESSED BY IB
09/12/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/25/2015
RFRR
REFUSAL PROCESSED BY MPU
08/25/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/25/2015
MAFR
APPLICATION FILING RECEIPT MAILED
08/25/2015
CNRT
NON-FINAL ACTION WRITTEN
08/24/2015
DOCK
ASSIGNED TO EXAMINER
08/19/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/19/2015
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/14/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/13/2015
Continuous trademark protection
Get notified about every new filing that threatens ORYZON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.